Multiple Myeloma Drug Side Effects Downplayed in Clinical Trials, Study Warns
A new study warns that multiple myeloma drug clinical trials often downplay the severity of side effects and adverse results, Johns Hopkins researchers warn.
A new study warns that multiple myeloma drug clinical trials often downplay the severity of side effects and adverse results, Johns Hopkins researchers warn.
The lawsuit blames Camp Lejeune water contamination for a U.S. Marine's son developing multiple myeloma.
The multiple myeloma drug Blenrep is being removed from the U.S. market after the fast-tracked cancer drug failed to perform in a recent clinical trial.
A new study suggests frequent Zometa injections increase the risk of jawbone death for some cancer patients.
The FDA warns that clinical trials indicate Venclexta can increase the risk of death when given off-label to patients for the treatment of multiple myeloma.
A Maine homeowner says he developed multiple myeloma after using Roundup to control weeds for years.
A new study warns that Kyprolis heart problems may be more widespread than previously believed.
After halting clinical trials involving the cancer drug Keytruda for treatment of multiple myeloma, the FDA has expanded the suspension to trials involving Opdivo, a similar medication.
Two clinical trials have been halted and the FDA is warning that Keytruda side effects may increase the risk of death when used with other drugs to treat multiple myeloma.
A Roundup lawsuit indicates that using the weed killer at home and at work resulted in an Illinois man contracting multiple myeloma.